Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis.
Adolescent
Adult
Connectome
/ methods
Executive Function
/ physiology
Female
Humans
Inhibition, Psychological
Magnetic Resonance Imaging
Male
Prefrontal Cortex
/ diagnostic imaging
Prodromal Symptoms
Psychomotor Performance
/ physiology
Psychotic Disorders
/ diagnostic imaging
Risk
Schizophrenia
/ diagnostic imaging
Young Adult
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
pubmed:
1
2
2018
medline:
20
6
2019
entrez:
1
2
2018
Statut:
ppublish
Résumé
Response inhibition (RI) is a component of the cognitive control systems that support optimal cognition. Cognitive control deficits are well-described in schizophrenia, but are not well characterized in individuals at clinical high risk (CHR) for developing psychosis. Functional magnetic resonance imaging during Go/NoGo task performance was collected from 30 CHR youth, 23 early illness schizophrenia patients (ESZ), and 72 healthy adolescents and young adults (HC). Voxelwise main effects of group were examined (P < .005 height threshold, family-wise error-corrected cluster threshold, P < .05) for correct NoGo-Go contrast values and task-based functional connectivity. CHR and ESZ groups had slower and more variable reaction times (RT) on Go trials compared to HCs. Significant main effects of group in bilateral dorsal anterior cingulate (dACC) and right inferior frontal cortex stemmed from CHR and ESZ groups showing significantly less NoGo-Go activation, relative to HCs. Faster responding HCs had less functional coupling between dACC and medial prefrontal cortex, a default mode network (DMN) region during NoGo vs Go trials. This functional connectivity-performance relationship was not present in ESZ or CHR groups. The pattern of findings suggests CHR and ESZ groups were deficient in developing strong and consistent prepotent responding, based on their slow and variable motor responses and decreased engagement of dACC and right inferior frontal regions implicated in inhibitory control. Furthermore, only the control group showed a functional connectivity relationship consistent with greater response prepotency requiring more decoupling of inhibitory control regions from DMN regions during RI.
Identifiants
pubmed: 29385625
pii: 4827879
doi: 10.1093/schbul/sbx198
pmc: PMC6293268
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
158-168Subventions
Organisme : NIMH NIH HHS
ID : U01 MH082022
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH076989
Pays : United States
Références
Behav Brain Res. 2013 Nov 1;256:529-36
pubmed: 23756137
Neuroimage. 2012 Jul 16;61(4):1277-86
pubmed: 22484411
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Neuroscientist. 2007 Jun;13(3):214-28
pubmed: 17519365
Biol Psychiatry. 2011 Dec 15;70(12):1151-8
pubmed: 21903198
Neuroimage. 2012 Jan 2;59(1):431-8
pubmed: 21810475
Arch Gen Psychiatry. 2009 Aug;66(8):811-22
pubmed: 19652121
Arch Gen Psychiatry. 2001 Mar;58(3):280-8
pubmed: 11231835
Neuropsychopharmacology. 2011 Jan;36(1):316-38
pubmed: 20844478
Neuroimage. 2006 Aug 15;32(2):704-13
pubmed: 16766210
Psychiatry Res. 2014 Jan 30;221(1):13-20
pubmed: 24120302
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Am J Psychiatry. 2005 Mar;162(3):475-84
pubmed: 15741464
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Neurosci Biobehav Rev. 2009 May;33(5):631-46
pubmed: 18835296
Biol Psychiatry. 2014 Mar 15;75(6):459-69
pubmed: 24050720
Arch Gen Psychiatry. 1996 Dec;53(12):1105-12
pubmed: 8956676
Biol Psychiatry. 2000 Jan 1;47(1):51-60
pubmed: 10650449
Neuropsychologia. 2008 Jan 15;46(1):224-32
pubmed: 17850833
Arch Gen Psychiatry. 2008 Jan;65(1):28-37
pubmed: 18180426
Biol Psychol. 2012 Jan;89(1):220-31
pubmed: 22027085
Schizophr Bull. 2006 Jan;32(1):179-94
pubmed: 16166612
Int J Psychophysiol. 2010 Oct;78(1):3-13
pubmed: 20580752
J Clin Psychiatry. 2003 Jun;64(6):663-7
pubmed: 12823080
Nat Neurosci. 2003 Feb;6(2):115-6
pubmed: 12536210
Neuroimage. 2007 Aug 1;37(1):90-101
pubmed: 17560126
Arch Gen Psychiatry. 2003 Mar;60(3):245-52
pubmed: 12622657
Science. 2000 Jun 9;288(5472):1835-8
pubmed: 10846167
Neuroimage Clin. 2015 Jul 31;9:95-102
pubmed: 26448909
Ann N Y Acad Sci. 2004 Jun;1021:296-309
pubmed: 15251900
Neuropsychopharmacology. 2016 Aug;41(9):2388-98
pubmed: 27067126
J Int Neuropsychol Soc. 2010 Nov;16(6):1064-76
pubmed: 20719043
Hum Brain Mapp. 2006 Dec;27(12):973-93
pubmed: 16683265
Neuroimage. 1997 Oct;6(3):218-29
pubmed: 9344826
Psychol Rev. 2007 Jul;114(3):830-41
pubmed: 17638508
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1231-8
pubmed: 12364845
Neuron. 2008 May 8;58(3):306-24
pubmed: 18466742
Psychophysiology. 2003 Sep;40(5):684-701
pubmed: 14696723
Hum Brain Mapp. 2005 May;25(1):35-45
pubmed: 15846821
Am J Psychiatry. 2002 May;159(5):863-5
pubmed: 11986145
Front Psychiatry. 2013 Sep 10;4:92
pubmed: 24032017
Nat Commun. 2014 Jun 06;5:4073
pubmed: 24905116
Schizophr Res. 2001 Oct 1;52(1-2):47-55
pubmed: 11595391
Neuroimage. 2011 Jun 1;56(3):1655-65
pubmed: 21376819
Exp Brain Res. 1970 Nov 26;11(4):376-86
pubmed: 4993199
J Abnorm Psychol. 2003 Nov;112(4):689-97
pubmed: 14674880
Arch Gen Psychiatry. 2004 Feb;61(2):119-29
pubmed: 14757588
Annu Rev Neurosci. 2001;24:167-202
pubmed: 11283309
Psychol Rev. 1992 Jan;99(1):45-77
pubmed: 1546118
Hum Brain Mapp. 2006 Aug;27(8):694-705
pubmed: 16404736
Schizophr Res. 2007 Dec;97(1-3):184-93
pubmed: 17855057
Acta Neuropsychiatr. 2010 Jun;22(3):127-138
pubmed: 21331320
J Cogn Neurosci. 2003 Apr 1;15(3):394-408
pubmed: 12729491
JAMA Psychiatry. 2016 Feb;73(2):113-20
pubmed: 26719911
Biol Psychiatry. 2008 Mar 1;63(5):490-7
pubmed: 17631280
Behav Brain Res. 2007 Jul 19;181(1):12-22
pubmed: 17467816
Biol Psychiatry. 2000 Aug 1;48(3):210-21
pubmed: 10924664
Neuropsychopharmacology. 2016 Apr;41(5):1241-50
pubmed: 26354046
Psychol Med. 2006 Apr;36(4):495-505
pubmed: 16336744
Schizophr Bull. 1977;3(3):373-428
pubmed: 335494
Neuroimage. 2014 Dec;103:65-74
pubmed: 25224995
Psychol Med. 2002 Feb;32(2):287-97
pubmed: 11866323
Science. 2004 Feb 13;303(5660):1023-6
pubmed: 14963333
Alcohol Clin Exp Res. 1992 Dec;16(6):1078-89
pubmed: 1471762
Arch Gen Psychiatry. 2003 Jan;60(1):57-65
pubmed: 12511173
Neuroimage. 2004 May;22(1):252-7
pubmed: 15110015
Nat Rev Neurosci. 2015 Dec;16(12):719-32
pubmed: 26530468
Brain Res. 1986 Sep 10;382(1):1-14
pubmed: 3768666